AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $119,000 | -33.5% | 15,894 | -19.4% | 0.00% | -100.0% |
| Q1 2022 | $179,000 | +51.7% | 19,717 | +18.0% | 0.00% | – |
| Q4 2021 | $118,000 | -70.5% | 16,710 | -52.4% | 0.00% | -100.0% |
| Q3 2021 | $400,000 | +12.0% | 35,122 | +45.1% | 0.00% | -50.0% |
| Q2 2020 | $357,000 | +5.6% | 24,200 | -3.2% | 0.00% | -33.3% |
| Q1 2020 | $338,000 | -65.7% | 25,000 | -38.6% | 0.00% | -57.1% |
| Q4 2019 | $984,000 | +327.8% | 40,700 | +239.2% | 0.01% | +250.0% |
| Q3 2019 | $230,000 | -39.3% | 12,000 | -6.4% | 0.00% | -33.3% |
| Q2 2019 | $379,000 | -54.5% | 12,817 | -5.2% | 0.00% | -25.0% |
| Q3 2018 | $833,000 | +54.0% | 13,515 | +68.7% | 0.00% | +33.3% |
| Q2 2018 | $541,000 | +147.0% | 8,013 | +98.2% | 0.00% | +200.0% |
| Q1 2018 | $219,000 | -12.0% | 4,042 | -2.7% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | +822.2% | 4,156 | +277.8% | 0.00% | – |
| Q4 2015 | $27,000 | +200.0% | 1,100 | +120.0% | 0.00% | – |
| Q2 2015 | $9,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
| Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
| March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
| DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
| Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
| Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
| PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
| NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
| HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
| Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |